Desensitization to acetylsalicylic acid in patients undergoing percutaneous coronary intervention. Experience in a tertiary center

Rev Esp Cardiol (Engl Ed). 2014 Jun;67(6):494-6. doi: 10.1016/j.rec.2014.01.022. Epub 2014 May 9.

Authors

Pablo Díez-Villanueva¹, Rafael Pineda², Pedro L Sánchez³, Pilar Tornero², Francisco Fernández-Avilés³

Affiliations

¹ Servicio de Cardiología, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Electronic address: pablo_diez_villanueva@hotmail.com.
² Servicio de Alergia, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
³ Servicio de Cardiología, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

PMID: 24863603
DOI: 10.1016/j.rec.2014.01.022

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Aspirin / adverse effects*
Desensitization, Immunologic*
Drug Hypersensitivity / etiology
Drug Hypersensitivity / therapy*
Female
Humans
Male
Middle Aged
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors / adverse effects*
Prospective Studies
Tertiary Care Centers

Substances

Platelet Aggregation Inhibitors
Aspirin